Latest Ghost Tree Capital, LLC Stock Portfolio
Ghost Tree Capital, LLC Performance:
2024 Q3: 6.19%YTD: 5%2023: -4.97%
Performance for 2024 Q3 is 6.19%, and YTD is 5%, and 2023 is -4.97%.
About Ghost Tree Capital, LLC and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Ghost Tree Capital, LLC reported an equity portfolio of $331 Millions as of 30 Sep, 2024.
The top stock holdings of Ghost Tree Capital, LLC are SRPT, , BPMC. The fund has invested 4.5% of it's portfolio in SAREPTA THERAPEUTICS INC and 4% of portfolio in NOVO-NORDISK A S.
The fund managers got completely rid off BIOHAVEN LTD, ACADIA PHARMACEUTICALS INC (ACAD) and CABALETTA BIO INC (CABA) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), SPYRE THERAPEUTICS INC (AGLE) and ENGENE HOLDINGS INC. Ghost Tree Capital, LLC opened new stock positions in NOVO-NORDISK A S, EDGEWISE THERAPEUTICS INC (EWTX) and DYNE THERAPEUTICS INC (DYN). The fund showed a lot of confidence in some stocks as they added substantially to JANUX THERAPEUTICS INC (JANX), BLUEPRINT MEDICINES CORP (BPMC) and SAREPTA THERAPEUTICS INC (SRPT).
The top stock holdings of Ghost Tree Capital, LLC are SRPT, , BPMC. The fund has invested 4.5% of it's portfolio in SAREPTA THERAPEUTICS INC and 4% of portfolio in NOVO-NORDISK A S.
The fund managers got completely rid off BIOHAVEN LTD, ACADIA PHARMACEUTICALS INC (ACAD) and CABALETTA BIO INC (CABA) stocks. They significantly reduced their stock positions in VIRIDIAN THERAPEUTICS INC (VRDN), SPYRE THERAPEUTICS INC (AGLE) and ENGENE HOLDINGS INC. Ghost Tree Capital, LLC opened new stock positions in NOVO-NORDISK A S, EDGEWISE THERAPEUTICS INC (EWTX) and DYNE THERAPEUTICS INC (DYN). The fund showed a lot of confidence in some stocks as they added substantially to JANUX THERAPEUTICS INC (JANX), BLUEPRINT MEDICINES CORP (BPMC) and SAREPTA THERAPEUTICS INC (SRPT).
Ghost Tree Capital, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Ghost Tree Capital, LLC made a return of 6.19% in the last quarter. In trailing 12 months, it's portfolio return was 17.67%.
New Buys
| Ticker | $ Bought |
|---|---|
| novo-nordisk a s | 13,097,700 |
| edgewise therapeutics inc | 5,204,550 |
| dyne therapeutics inc | 3,592,000 |
| corvus pharmaceuticals inc | 2,640,000 |
| absci corporation | 2,101,000 |
| capricor therapeutics inc | 1,901,250 |
| summit therapeutics inc | 1,861,500 |
| larimar therapeutics inc | 1,310,000 |
New stocks bought by Ghost Tree Capital, LLC
Additions
| Ticker | % Inc. |
|---|---|
| janux therapeutics inc | 280 |
| blueprint medicines corp | 250 |
| sarepta therapeutics inc | 118 |
| annexon inc | 109 |
| arvinas inc | 93.33 |
| taysha gene therapies inc | 72.00 |
| regenxbio inc | 55.88 |
| tarsus pharmaceuticals inc | 48.94 |
Additions to existing portfolio by Ghost Tree Capital, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| viridian therapeutics inc | -87.24 |
| spyre therapeutics inc | -76.02 |
| engene holdings inc | -61.72 |
| moonlake immunotherapeutics | -57.2 |
| apellis pharmaceuticals inc | -51.85 |
| soleno therapeutics inc | -50.00 |
| vaxcyte inc | -46.67 |
| ascendis pharma a/s | -39.46 |
Ghost Tree Capital, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| elevation oncology inc | -1,620,000 |
| biohaven ltd | -17,007,900 |
| pmv pharmaceuticals inc | -607,500 |
| cabaletta bio inc | -2,774,320 |
| cytomx therapeutics inc | -366,000 |
| acadia pharmaceuticals inc | -3,656,250 |
| revance therapeutics inc | -578,250 |
| sagimet biosciences inc | -769,500 |
Ghost Tree Capital, LLC got rid off the above stocks
Sector Distribution
Ghost Tree Capital, LLC has about 81.2% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 81.2 |
| Others | 18.8 |
Market Cap. Distribution
Ghost Tree Capital, LLC has about 7.4% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 37.2 |
| SMALL-CAP | 30.4 |
| UNALLOCATED | 18.8 |
| LARGE-CAP | 7.4 |
| MICRO-CAP | 6.2 |
Stocks belong to which Index?
About 57.7% of the stocks held by Ghost Tree Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 57.7 |
| Others | 42.3 |
Ghost Tree Capital, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Ghost Tree Capital, LLC
Ghost Tree Capital, LLC has 50 stocks in it's portfolio. About 33.6% of the portfolio is in top 10 stocks. CRBP proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for Ghost Tree Capital, LLC last quarter.
Last Reported on: 14 Nov, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABSI | absci corporation | 0.64 | 550,000 | 2,101,000 | new | |||
| ACAD | acadia pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AGLE | spyre therapeutics inc | 0.53 | 60,000 | 1,764,600 | reduced | -76.02 | ||
| AMLX | amylyx pharmaceuticals inc | 0.32 | 325,000 | 1,053,000 | new | |||
| ANNX | annexon inc | 1.16 | 650,000 | 3,848,000 | added | 109 | ||
| ANTX | an2 therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| APLS | apellis pharmaceuticals inc | 0.57 | 65,000 | 1,874,600 | reduced | -51.85 | ||
| ARVN | arvinas inc | 1.08 | 145,000 | 3,571,350 | added | 93.33 | ||
| ARWR | arrowhead pharmaceuticals in | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AXSM | axsome therapeutics inc | 3.66 | 135,000 | 12,132,400 | reduced | -10.00 | ||
| BBIO | bridgebio pharma inc | 1.35 | 175,000 | 4,455,500 | added | 25.00 | ||
| BPMC | blueprint medicines corp | 3.91 | 140,000 | 12,950,000 | added | 250 | ||
| CABA | cabaletta bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CAPR | capricor therapeutics inc | 0.57 | 125,000 | 1,901,250 | new | |||
| CRBP | corbus pharmaceuticals hldgs | 1.00 | 160,000 | 3,300,800 | reduced | -8.57 | ||
| CRNX | crinetics pharmaceuticals in | 2.32 | 150,000 | 7,665,000 | reduced | -37.5 | ||
| CRVS | corvus pharmaceuticals inc | 0.80 | 500,000 | 2,640,000 | new | |||
| CTMX | cytomx therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CYTK | cytokinetics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| DYN | dyne therapeutics inc | 1.08 | 100,000 | 3,592,000 | new | |||